VHI vs. KSI, DR, OGI, QIPT, CPH, FRX, CRDL, HLS, SVA, and MDNA
Should you be buying Vitalhub stock or one of its competitors? The main competitors of Vitalhub include kneat.com (KSI), Medical Facilities (DR), Organigram (OGI), Quipt Home Medical (QIPT), Cipher Pharmaceuticals (CPH), Fennec Pharmaceuticals (FRX), Cardiol Therapeutics (CRDL), HLS Therapeutics (HLS), Sernova (SVA), and Medicenna Therapeutics (MDNA). These companies are all part of the "medical" sector.
Vitalhub (TSE:VHI) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, community ranking, institutional ownership, valuation, dividends and profitability.
Vitalhub has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, kneat.com has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.
Vitalhub received 4 more outperform votes than kneat.com when rated by MarketBeat users. However, 100.00% of users gave kneat.com an outperform vote while only 62.50% of users gave Vitalhub an outperform vote.
Vitalhub has a net margin of 8.66% compared to kneat.com's net margin of -41.26%. Vitalhub's return on equity of 5.78% beat kneat.com's return on equity.
22.2% of Vitalhub shares are owned by institutional investors. Comparatively, 10.4% of kneat.com shares are owned by institutional investors. 21.1% of Vitalhub shares are owned by insiders. Comparatively, 24.9% of kneat.com shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
In the previous week, kneat.com had 1 more articles in the media than Vitalhub. MarketBeat recorded 1 mentions for kneat.com and 0 mentions for Vitalhub. kneat.com's average media sentiment score of 0.59 beat Vitalhub's score of 0.00 indicating that kneat.com is being referred to more favorably in the news media.
Vitalhub presently has a consensus target price of C$6.42, indicating a potential upside of 2.67%. Given Vitalhub's higher possible upside, research analysts plainly believe Vitalhub is more favorable than kneat.com.
Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.
Summary
Vitalhub beats kneat.com on 12 of the 17 factors compared between the two stocks.
Get Vitalhub News Delivered to You Automatically
Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vitalhub Competitors List
Related Companies and Tools
